Chapter 9: The White Cells, Part 2: Lymphocytes and Their Benign Disorders

The White Cells, Part 2: Lymphocytes and Their Benign Disorders details the maturation process occurring within primary lymphoid organs, where B cells develop in the bone marrow and T cells undergo rigorous selection in the thymus before migrating to secondary lymphoid tissues like the spleen and lymph nodes to initiate immune responses. The text explores the molecular architecture of the B-cell receptor and the complex genetic mechanisms of rearrangement that allow for the production of highly specific immunoglobulins, covering the distinct roles of the IgM, IgG, IgA, IgD, and IgE isotypes. Special attention is given to the differentiation of T-cell subsets into helper and cytotoxic varieties, which operate under strict human leucocyte antigen restriction to identify and neutralize internal and external threats. Modern therapeutic techniques, such as the bioengineering of chimeric antigen receptor T cells for targeted cancer therapy, are highlighted alongside the innate immune roles of natural killer cells and the enzymatic complement cascade that facilitates pathogen destruction through opsonization and lysis. In addition to normal physiological functions, the chapter provides a deep dive into clinical conditions like lymphocytosis, specifically focusing on the pathogenesis, clinical presentation, and laboratory diagnosis of infectious mononucleosis caused by the Epstein-Barr virus. It concludes by outlining a systematic diagnostic framework for assessing lymphadenopathy and classifying various forms of immunodeficiency, ranging from primary genetic defects like X-linked agammaglobulinaemia to secondary states induced by malignancies, infections, or medical interventions.